Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (221-230 of 287) with videos related to

Pageof 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Postoperative hyperprolactinaemia and early recurrence rate in breast cancerP Lissoni, A L Sormani, G Tancini, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1991
Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatoninP Lissoni, E Tisi, F Brivio, et al.
British Journal of Cancer|November 1, 1991
Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2P Lissoni, F Brivio, S Pittalis, et al.
The International Journal of Biological Markers|April 19, 2005
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival resultsA Bignami, P Lissoni, F Brivio, et al.
Journal of Pineal Research|August 1, 1997
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical stateP Lissoni, F Paolorossi, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|February 24, 2001
Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic diseaseP Lissoni, F Brivio, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Acute endocrine effects of interleukin-12 in cancer patientsP Lissoni, F Rovelli, M R Rivolta, et al.
Journal of Biological Regulators and Homeostatic Agents|March 7, 2000
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic diseaseP Lissoni, L Vigore, R Ferranti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancerP Lissoni, S Barni, E Tisi, et al.
The International Journal of Biological Markers|April 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to CD4/CD8 ratio in patients with advanced solid tumorsG Tancini, P Lissoni, S Barni, et al.
Pageof 29

Showing results (221-230 of 287) with videos related to

Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Postoperative hyperprolactinaemia and early recurrence rate in breast cancerP Lissoni, A L Sormani, G Tancini, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1991
Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatoninP Lissoni, E Tisi, F Brivio, et al.
British Journal of Cancer|November 1, 1991
Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2P Lissoni, F Brivio, S Pittalis, et al.
The International Journal of Biological Markers|April 19, 2005
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival resultsA Bignami, P Lissoni, F Brivio, et al.
Journal of Pineal Research|August 1, 1997
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical stateP Lissoni, F Paolorossi, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|February 24, 2001
Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic diseaseP Lissoni, F Brivio, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Acute endocrine effects of interleukin-12 in cancer patientsP Lissoni, F Rovelli, M R Rivolta, et al.
Journal of Biological Regulators and Homeostatic Agents|March 7, 2000
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic diseaseP Lissoni, L Vigore, R Ferranti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancerP Lissoni, S Barni, E Tisi, et al.
The International Journal of Biological Markers|April 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to CD4/CD8 ratio in patients with advanced solid tumorsG Tancini, P Lissoni, S Barni, et al.
Pageof 29